Releases › ICD-10-PCS FY2016

ICD-10-PCS FY2016

Effective 2015-10-01 to 2016-09-30. 71,974 codes in the release.

53added
0revised
0removed

Codes added 53

CodeDescription
047K041 Dilation of Right Femoral Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Open Approach
047K0D1 Dilation of Right Femoral Artery with Intraluminal Device, using Drug-Coated Balloon, Open Approach
047K0Z1 Dilation of Right Femoral Artery using Drug-Coated Balloon, Open Approach
047K341 Dilation of Right Femoral Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Percutaneous Approach
047K3D1 Dilation of Right Femoral Artery with Intraluminal Device, using Drug-Coated Balloon, Percutaneous Approach
047K3Z1 Dilation of Right Femoral Artery using Drug-Coated Balloon, Percutaneous Approach
047K441 Dilation of Right Femoral Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Percutaneous Endoscopic Approach
047K4D1 Dilation of Right Femoral Artery with Intraluminal Device, using Drug-Coated Balloon, Percutaneous Endoscopic Approach
047K4Z1 Dilation of Right Femoral Artery using Drug-Coated Balloon, Percutaneous Endoscopic Approach
047L041 Dilation of Left Femoral Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Open Approach
047L0D1 Dilation of Left Femoral Artery with Intraluminal Device, using Drug-Coated Balloon, Open Approach
047L0Z1 Dilation of Left Femoral Artery using Drug-Coated Balloon, Open Approach
047L341 Dilation of Left Femoral Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Percutaneous Approach
047L3D1 Dilation of Left Femoral Artery with Intraluminal Device, using Drug-Coated Balloon, Percutaneous Approach
047L3Z1 Dilation of Left Femoral Artery using Drug-Coated Balloon, Percutaneous Approach
047L441 Dilation of Left Femoral Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Percutaneous Endoscopic Approach
047L4D1 Dilation of Left Femoral Artery with Intraluminal Device, using Drug-Coated Balloon, Percutaneous Endoscopic Approach
047L4Z1 Dilation of Left Femoral Artery using Drug-Coated Balloon, Percutaneous Endoscopic Approach
047M041 Dilation of Right Popliteal Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Open Approach
047M0D1 Dilation of Right Popliteal Artery with Intraluminal Device, using Drug-Coated Balloon, Open Approach
047M0Z1 Dilation of Right Popliteal Artery using Drug-Coated Balloon, Open Approach
047M341 Dilation of Right Popliteal Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Percutaneous Approach
047M3D1 Dilation of Right Popliteal Artery with Intraluminal Device, using Drug-Coated Balloon, Percutaneous Approach
047M3Z1 Dilation of Right Popliteal Artery using Drug-Coated Balloon, Percutaneous Approach
047M441 Dilation of Right Popliteal Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Percutaneous Endoscopic Approach
047M4D1 Dilation of Right Popliteal Artery with Intraluminal Device, using Drug-Coated Balloon, Percutaneous Endoscopic Approach
047M4Z1 Dilation of Right Popliteal Artery using Drug-Coated Balloon, Percutaneous Endoscopic Approach
047N041 Dilation of Left Popliteal Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Open Approach
047N0D1 Dilation of Left Popliteal Artery with Intraluminal Device, using Drug-Coated Balloon, Open Approach
047N0Z1 Dilation of Left Popliteal Artery using Drug-Coated Balloon, Open Approach
047N341 Dilation of Left Popliteal Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Percutaneous Approach
047N3D1 Dilation of Left Popliteal Artery with Intraluminal Device, using Drug-Coated Balloon, Percutaneous Approach
047N3Z1 Dilation of Left Popliteal Artery using Drug-Coated Balloon, Percutaneous Approach
047N441 Dilation of Left Popliteal Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Percutaneous Endoscopic Approach
047N4D1 Dilation of Left Popliteal Artery with Intraluminal Device, using Drug-Coated Balloon, Percutaneous Endoscopic Approach
047N4Z1 Dilation of Left Popliteal Artery using Drug-Coated Balloon, Percutaneous Endoscopic Approach
X2C New Technology, Cardiovascular System, Extirpation
X2C0361 Extirpation of Matter from Coronary Artery, One Site using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1
X2C1361 Extirpation of Matter from Coronary Artery, Two Sites using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1
X2C2361 Extirpation of Matter from Coronary Artery, Three Sites using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1
X2C3361 Extirpation of Matter from Coronary Artery, Four or More Sites using Orbital Atherectomy Technology, Percutaneous Approach, New Technology Group 1
XR2 New Technology, Joints, Monitoring
XR2G021 Monitoring of Right Knee Joint using Intraoperative Knee Replacement Sensor, Open Approach, New Technology Group 1
XR2H021 Monitoring of Left Knee Joint using Intraoperative Knee Replacement Sensor, Open Approach, New Technology Group 1
XW0 New Technology, Anatomical Regions, Introduction
XW03321 Introduction of Ceftazidime-Avibactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 1
XW03331 Introduction of Idarucizumab, Dabigatran Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 1
XW03341 Introduction of Isavuconazole Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 1
XW03351 Introduction of Blinatumomab Antineoplastic Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 1
XW04321 Introduction of Ceftazidime-Avibactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 1
XW04331 Introduction of Idarucizumab, Dabigatran Reversal Agent into Central Vein, Percutaneous Approach, New Technology Group 1
XW04341 Introduction of Isavuconazole Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 1
XW04351 Introduction of Blinatumomab Antineoplastic Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 1